CapsoVision, Inc. (CV) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped CV stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: CapsoVision appears to be positioned for substantial growth opportunities, bolstered by strategic partnerships, innovative developments, and healthtech market dynamics. While challenges such as the legal disputes exist, the overall positive momentum in the business environment suggests a net positive outlook. The saved 1-year distribution is P10 $5.5, P50 $10.25, and P90 $14.75.
Last analyzed · Model: gpt-4o
CapsoVision, Inc. Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $5.5 | Pessimistic plausible scenario |
| P50 | $10.25 | Median scenario |
| P90 | $14.75 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
CapsoVision has experienced a significant price drop recently, most likely attributed to market jitters or specific news. Despite this, the company has received consensus BUYS from analysts, and recent developments, including partnerships and product launches, paint a positive outlook for the future.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this CV analysis generated?
April 1, 2026.
Is this a guaranteed CV prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full CV stock analysis · CV sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.